Pr Thomas Decaens
- Spécialité
- Oncologue médical, expert foie
- Titre
- Chef de service
- Hôpital
- Centre Hospitalier Université Grenoble Alpes (Grenoble)
- Derniers articles
-
- Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW - Authors' reply. (22 nov. 2025)
- Corrigendum to: "Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study" [J Hepatol (2024) 278-288]. (27 oct. 2025)
- A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (1 oct. 2025)
- Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. (1 oct. 2025)
- Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (1 sept. 2025)